Impact of Parathyroidectomy on Renal Function
NCT04798092 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2022-12-05
Summary
Primary hyperparathyroidism (PHPT) is a disorder of one or more of the parathyroid glands. The parathyroid gland(s) becomes overactive and secretes excess amounts of parathyroid hormone (PTH). As a result, the blood calcium rises to a level that is higher than normal. PHPT is associated with several other metabolic complications as osteoporosis, kidney stones, hypertension, insulin resistance, cardiac calcifications, cardiac arrhythmias, and kidney failure. Renal function deterioration over time has also been reported. However, the role of parathyroidectomy on renal function remains controversial in patients with PHPT. In some studies, surgical cure of PHPT has been shown to halt renal function deterioration in patients with coexisting renal disease. On the other hand, other studies showed no significant impact of parathyroidectomy on renal function. Consequently, the goal of this study was to evaluate renal function before and after parathyroidectomy in a large cohort of patients with pHPT.
Conditions
- Primary Hyperparathyroidism
Interventions
- PROCEDURE
-
parathyroidectomy
surgical removal of parathyroid adenoma(s) with postoperative biological cure
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Principal Investigators
-
Brunaud · CHU NANCY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-01
- Primary Completion
- 2023-01-31
- Completion
- 2023-01-31
Countries
- France
Study Locations
More Related Trials
-
FGF-23 and PTH in Hemodialysis Patients
NCT04350944 ·Status: COMPLETED
-
DePTH: De-emphasize PTH
NCT06288451 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA
NCT02830009 ·Status: COMPLETED ·Phase: NA
-
the Study on Prognostic for Hemodialysis Patients
NCT03194087 ·Status: UNKNOWN
-
Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.
NCT03182517 ·Status: UNKNOWN
-
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
NCT00975000 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
NCT03937349 ·Status: COMPLETED
-
Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients
NCT01447368 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.
NCT01939977 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients
NCT01640184 ·Status: COMPLETED ·Phase: NA
-
The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD
NCT06398002 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Registry for Hypoparathyroidism Wuerzburg
NCT05585593 ·Status: RECRUITING
-
Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.
NCT00744302 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Influence of Dosages of 1-84 and 7-84 Fragments of Parathyroid Hormone Compared to Conventional Dosage on the Balance of Calcium and Phosphate in Hemodialysis (PTH)
NCT02859220 ·Status: COMPLETED ·Phase: NA
-
Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism
NCT00307840 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients
NCT03082742 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Cincalcet Suppression Test
NCT01103206 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis
NCT00646035 ·Status: COMPLETED ·Phase: PHASE3
-
Causes, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German Hospital
NCT06467877 ·Status: ACTIVE_NOT_RECRUITING
-
Pharmacoepidemiological Study of Secondary Hyperparathyroidism in Lorraine
NCT02888639 ·Status: COMPLETED
-
A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients
NCT01506947 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
NCT00664430 ·Status: TERMINATED ·Phase: PHASE4
-
Low Salt Diet in Idiopathic Hypercalciuria
NCT01005082 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PTH-independent Effects of Encaleret
NCT05735015 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol
NCT01748396 ·Status: COMPLETED ·Phase: PHASE4